亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

医学 肺癌 阶段(地层学) 置信区间 放射治疗 不利影响 随机对照试验 放射科 核医学 外科 内科学 古生物学 生物
作者
Gregory M.M. Videtic,Chen Hu,Anurag K. Singh,Joe Y. Chang,William Parker,Kenneth R. Olivier,Steven E. Schild,Ritsuko Komaki,James J. Urbanic,Hak Choy
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:93 (4): 757-764 被引量:326
标识
DOI:10.1016/j.ijrobp.2015.07.2260
摘要

To compare 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable early-stage lung cancer to determine which produces the lowest rate of grade ≥3 protocol-specified adverse events (psAEs) at 1 year.Patients with biopsy-proven peripheral (≥2 cm from the central bronchial tree) T1 or T2, N0 (clinically node negative by positron emission tomography), M0 tumors were eligible. Patients were randomized to receive either 34 Gy in 1 fraction (arm 1) or 48 Gy in 4 consecutive daily fractions (arm 2). Rigorous central accreditation and quality assurance confirmed treatment per protocol guidelines. This study was designed to detect a psAEs rate >17% at a 10% significance level (1-sided) and 90% power. Secondary endpoints included rates of primary tumor control (PC), overall survival (OS), and disease-free survival (DFS) at 1 year. Designating the better of the 2 regimens was based on prespecified rules of psAEs and PC for each arm.Ninety-four patients were accrued between September 2009 and March 2011. The median follow-up time was 30.2 months. Of 84 analyzable patients, 39 were in arm 1 and 45 in arm 2. Patient and tumor characteristics were balanced between arms. Four (10.3%) patients on arm 1 (95% confidence interval [CI] 2.9%-24.2%) and 6 (13.3%) patients on arm 2 (95% CI 5.1%-26.8%) experienced psAEs. The 2-year OS rate was 61.3% (95% CI 44.2%-74.6%) for arm 1 patients and 77.7% (95% CI 62.5%-87.3%) for arm 2. The 2-year DFS was 56.4% (95% CI 39.6%-70.2%) for arm 1 and 71.1% (95% CI 55.5%-82.1%) for arm 2. The 1-year PC rate was 97.0% (95% CI 84.2%-99.9%) for arm 1 and 92.7% (95% CI 80.1%-98.5%) for arm 2.34 Gy in 1 fraction met the prespecified criteria and, of the 2 schedules, warrants further clinical research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Plum22发布了新的文献求助10
19秒前
37秒前
啊哦额发布了新的文献求助10
43秒前
51秒前
qq发布了新的文献求助10
54秒前
Akitten完成签到,获得积分10
57秒前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
GingerF应助科研通管家采纳,获得10
1分钟前
GingerF应助科研通管家采纳,获得20
1分钟前
GingerF应助科研通管家采纳,获得10
1分钟前
酷波er应助科研通管家采纳,获得10
1分钟前
MchemG应助科研通管家采纳,获得30
1分钟前
大胆梦容关注了科研通微信公众号
1分钟前
Xw关闭了Xw文献求助
1分钟前
Plum22驳回了Lucas应助
1分钟前
李健的粉丝团团长应助kohu采纳,获得10
1分钟前
qq完成签到,获得积分10
2分钟前
思源应助Akitten采纳,获得30
2分钟前
2分钟前
2分钟前
童大大发布了新的文献求助10
2分钟前
淡漠发布了新的文献求助10
2分钟前
廖庭毅完成签到,获得积分20
2分钟前
汉堡包应助wen采纳,获得10
2分钟前
秋天完成签到,获得积分10
2分钟前
汉堡包应助科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
NexusExplorer应助Luo采纳,获得10
3分钟前
3分钟前
Luo发布了新的文献求助10
3分钟前
wintersss完成签到,获得积分10
3分钟前
3分钟前
Plum22发布了新的文献求助20
3分钟前
廖庭毅发布了新的文献求助10
3分钟前
3分钟前
4分钟前
山是山三十三完成签到 ,获得积分10
4分钟前
核桃发布了新的文献求助10
4分钟前
斯文败类应助科研通管家采纳,获得10
5分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990105
求助须知:如何正确求助?哪些是违规求助? 3532119
关于积分的说明 11256456
捐赠科研通 3271016
什么是DOI,文献DOI怎么找? 1805171
邀请新用户注册赠送积分活动 882288
科研通“疑难数据库(出版商)”最低求助积分说明 809228